JESSICA SEXTON: Open Payments
NPI 1508124223 · ONEIDA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 60 payments from 17 companies in 2025. Trend: 2023 $943 · 2024 $738 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $196 |
| GlaxoSmithKline, LLC. | 9 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $91 |
| Novo Nordisk Inc | 4 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 1 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Averitas Pharma Inc. | 1 | $29 |
Products named: TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, Kerendia, XIFAXAN, UBRELVY, AIRSUPRA, Wegovy.
Industry payments across TN — which companies pay providers there.
